Suppr超能文献

一项关于墨西哥人和有常染色体显性阿尔茨海默病风险的墨西哥裔美国人对痴呆症和基因检测的文化信仰的混合方法研究。

A mixed-methods study of cultural beliefs about dementia and genetic testing among Mexicans and Mexican-Americans at-risk for autosomal dominant Alzheimer's disease.

作者信息

Withers Mellissa, Sayegh Philip, Rodriguez-Agudelo Yaneth, Ernstrom Karin, Raman Rema, Montoya Lucy, Zuno-Reyes Angelica, Mosieri Chizoba, Matute Esmeralda, Ringman John M

机构信息

Keck School of Medicine, University of Southern California, Los Angeles, California.

Department of Psychology, University of California, Los Angeles, California.

出版信息

J Genet Couns. 2019 Oct;28(5):921-932. doi: 10.1002/jgc4.1133. Epub 2019 Jun 17.

Abstract

Trials to prevent autosomal dominantly inherited Alzheimer's disease (ADAD) are critical and timely. However, cultural beliefs about AD and genetic testing may preclude informed consent and participation, especially among racial/ethnic minorities. This mixed-methods study examines cultural beliefs about AD and genetic screening among at-risk populations of Mexican heritage. We surveyed 86 Mexican and 37 Mexican-American family members of patients with ADAD and interviewed 18 respondents in Mexico to explore perceptions and knowledge regarding AD and genetic testing. While most respondents understood that AD is inherited in their families, they also had limited understanding of the genetic mechanisms behind AD. Many believed that AD is a normal part of aging or that it is a mental illness caused by bad habits. However, beliefs that AD is caused by a curse or God's will were uncommon. The interviews demonstrated that very few at-risk respondents understood their own risk for harboring the mutation causing AD in their family. Once informed, most expressed a strong interest in genetic testing, largely motivated by the desire to be better prepared for the development of AD. Health professionals treating and investigators enrolling members from families with ADAD cannot assume that they fully understand the nature of the illness; therefore, providers should provide comprehensive information about ADAD and genetic testing.

摘要

预防常染色体显性遗传阿尔茨海默病(ADAD)的试验至关重要且时机恰当。然而,关于阿尔茨海默病和基因检测的文化观念可能会妨碍知情同意和参与,尤其是在少数种族/族裔群体中。这项混合方法研究考察了墨西哥裔高危人群对阿尔茨海默病和基因筛查的文化观念。我们对86名墨西哥人和37名患有ADAD患者的墨西哥裔美国家庭成员进行了调查,并采访了墨西哥的18名受访者,以探讨他们对阿尔茨海默病和基因检测的看法及了解程度。虽然大多数受访者明白阿尔茨海默病在其家族中具有遗传性,但他们对阿尔茨海默病背后的遗传机制了解有限。许多人认为阿尔茨海默病是衰老的正常部分,或者认为它是由不良习惯导致的精神疾病。然而,认为阿尔茨海默病是由诅咒或上帝意志引起的观念并不常见。访谈表明,很少有高危受访者了解自己携带家族中导致阿尔茨海默病突变的风险。一旦被告知,大多数人表示对基因检测有浓厚兴趣,主要动机是希望为阿尔茨海默病的发展做好更充分准备。治疗患有ADAD家庭成员的医护人员以及招募这些家庭成员的研究人员不能假定他们完全理解这种疾病的本质;因此,医疗服务提供者应该提供有关ADAD和基因检测的全面信息。

相似文献

3
Suicidal ideation is common in autosomal dominant Alzheimer's disease at-risk persons.
Int J Geriatr Psychiatry. 2020 Jan;35(1):60-68. doi: 10.1002/gps.5215. Epub 2019 Oct 22.
4
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
Acta Neuropathol Commun. 2018 Nov 26;6(1):130. doi: 10.1186/s40478-018-0624-z.
8
Seizures as an early symptom of autosomal dominant Alzheimer's disease.
Neurobiol Aging. 2019 Apr;76:18-23. doi: 10.1016/j.neurobiolaging.2018.11.022. Epub 2018 Dec 5.
9
Genetic testing in familial AD and FTD: mutation and phenotype spectrum in a Danish cohort.
Clin Genet. 2009 Aug;76(2):205-9. doi: 10.1111/j.1399-0004.2009.01191.x. Epub 2009 Jul 29.

引用本文的文献

2
Research methodologies in genetic counseling: Grounded theory.
J Genet Couns. 2025 Jun;34(3):e70060. doi: 10.1002/jgc4.70060.
6
Beliefs About the Causes of Alzheimer's Disease Among Latinos in New York City.
J Community Health. 2025 Feb;50(1):10-22. doi: 10.1007/s10900-024-01386-x. Epub 2024 Aug 23.
7
The effect of years of schooling and age on CERAD-MX performance in Mexican preclinical carriers of the mutation: Randomized data simulation.
Alzheimers Dement (Amst). 2024 Aug 21;16(3):e12631. doi: 10.1002/dad2.12631. eCollection 2024 Jul-Sep.
9
Communicating genetic risk status for NAFLD among Mexican-origin men.
Front Public Health. 2023 Jan 4;10:1090101. doi: 10.3389/fpubh.2022.1090101. eCollection 2022.

本文引用的文献

1
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.
4
Exploring Willingness to Participate in Clinical Trials by Ethnicity.
J Racial Ethn Health Disparities. 2017 Aug;4(4):763-769. doi: 10.1007/s40615-016-0280-6. Epub 2016 Sep 7.
5
Systematic review of dementia prevalence and incidence in United States race/ethnic populations.
Alzheimers Dement. 2017 Jan;13(1):72-83. doi: 10.1016/j.jalz.2016.06.2360. Epub 2016 Sep 4.
6
The worldwide costs of dementia 2015 and comparisons with 2010.
Alzheimers Dement. 2017 Jan;13(1):1-7. doi: 10.1016/j.jalz.2016.07.150. Epub 2016 Aug 29.
7
Mexican-American perspectives on participation in clinical trials: A qualitative study.
Contemp Clin Trials Commun. 2016 Dec 15;4:52-57. doi: 10.1016/j.conctc.2016.06.009. Epub 2016 Jun 27.
8
Daily Activity Abilities in MCI, Alzheimer's Disease, and Healthy Controls.
GeroPsych (Bern). 2015 Dec;28(4):191-200. doi: 10.1024/1662-9647/a000136. Epub 2015 Nov 26.
9
10
A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease.
Alzheimers Res Ther. 2015 Jul 22;7(1):50. doi: 10.1186/s13195-015-0135-0. eCollection 2015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验